Replies to post #304884 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

They have a 5-year deal with Lyell [1], and testing their NY-ESO-1 TCR-T cell product with either a CD8a [2] or dnTGFßRII [2].

Ref
1 https://www.gsk.com/en-gb/media/press-releases/gsk-and-lyell-immunopharma-join-forces-to-develop-the-next-generation-of-cancer-cell-therapies/
2 (ADAP has helped with some of the R&D) https://www.adaptimmune.com/our-company/perspectives/detail/1153/jon-silk-talks-about-our-next-generation-research